Volnewmer RF Lifting: Turkey Istanbul / What the Science Actually Says
- KAĞAN CİNGÖZ
- Mar 25
- 5 min read

This article explains how Volnewmer works at a biological level, what peer-reviewed clinical studies have measured, and how it differs from HIFU. No marketing language — just the science behind the device.
1. How Does Radiofrequency Energy Affect the Skin?
Radiofrequency (RF) energy operates within the 0.5–40 MHz electromagnetic spectrum. When applied to skin, it penetrates below the surface without damaging the epidermis and generates controlled heat in the dermis and subcutaneous layers.
The biological response unfolds in three phases:
• Immediate effect: Thermal stress causes collagen fibers to denature — their triple-helix structure partially unwinds and the fibers shorten. This produces the immediate tightening sensation during and after treatment.
• Delayed phase — Neocollagenesis: Heat acts as a controlled stimulus. Fibroblasts are activated and, via TGF-β signaling, upregulate synthesis of Type I and Type III collagen and elastin. This process continues for weeks after treatment.
• ECM remodeling: Reorganization of glycosaminoglycans, proteoglycans, and other extracellular matrix components contributes to increased skin thickness and elasticity over time.
⚠️ Important: When thermal energy is applied incorrectly or in excess, it can cause irreversible tissue damage rather than collagen remodeling. Device selection, energy dosing, and technique are therefore clinically critical. |
2. What Is Volnewmer? Technical Profile
Volnewmer is a monopolar radiofrequency system developed by Classys Inc. (South Korea), manufacturer of the Ultraformer HIFU and BBL platforms. It carries FDA clearance and Korean MFDS certification.
Parameter | Specification |
Operating frequency | 6.78 MHz monopolar RF |
Maximum power | 115 Watts |
Cooling system | Continuous water cooling (12–20°C) — not pulsed cryogen gas |
Impedance detection | Real-time; energy delivery stops if tip contact is lost |
Tip sizes | I: 0.25 cm² (periocular), F: 3.0 cm², V: 4.0 cm², S: 16.0 cm² (body) |
Tip coating | Gold-plated — improves energy delivery uniformity |
Monopolar vs. Bipolar RF — Why It Matters
• Monopolar RF: Energy travels between the tip and a grounding electrode placed on the body, enabling deep penetration into dermis and subcutaneous tissue. Volnewmer is monopolar.
• Bipolar RF: Energy passes between two adjacent tips at a shallower depth. RF microneedling devices (e.g., Morpheus8) typically use bipolar or fractional RF.
As noted in dermatology literature, monopolar electrodes achieve greater penetration into subcutaneous tissue for substantial collagen remodeling — volumetric heating rather than surface-level treatment.
3. Continuous Water Cooling — Why It Differentiates
• Traditional monopolar RF devices (e.g., Thermage) use pulsed cryogen gas for surface protection. Volnewmer circulates water at 12–20°C continuously.
• Continuous cooling allows higher energy to reach the dermis while keeping the epidermis safe — and significantly reduces procedural discomfort.
• A 2025 split-face study (Annals of Dermatology) directly compared Volnewmer (RF-CWC) against Thermage FLX (RF-CSC). Ex vivo data confirmed comparable collagen and elastin fiber density improvements — with meaningfully lower pain scores for the water-cooled system.
4. Clinical Studies — What the Data Actually Shows
Study 1 — 3D Facial Lifting Analysis (PRS Global Open, Sept 2024)
Parameter | Data |
Publication | Plastic & Reconstructive Surgery – Global Open | September 2024 |
Cohort | 30 Korean women, single session |
Method | 3D laser scanner — millimetric lifting measured across 5 facial zones |
Mid-cheek (immediate) | 1.88 ± 0.76 mm |
Neck (immediate) | 2.66 ± 1.40 mm — largest improvement |
Lower face (immediate) | 1.79 ± 0.91 mm |
Lateral orbital rim | 1.62 ± 0.99 mm |
1-month follow-up | Lifting maintained in all zones (p < 0.05) |
Skin texture score | Higher at 1 month than immediately — consistent with ongoing collagen remodeling |
Study 2 — Wrinkle and Surface Roughness (PRS Global Open, Feb 2024)
Parameter | Data |
Publication | Plastic & Reconstructive Surgery – Global Open | February 2024 |
Cohort | 50 participants; 45 completed |
Method | 3D scanner — Ra (average surface roughness) measured objectively |
Immediate improvement | Ra dropped from 16.71 to 11.88 → 28.42% improvement |
1-month follow-up | Ra at 12.33 → 26.23% sustained improvement |
Study 3 — Volume and Cheek Laxity (Tandfonline, Jul 2024)
Parameter | Data |
Publication | Journal of Dermatological Treatment | July 2024 |
Cohort | 21 Asian patients, single session, no anesthetic |
Target group | Mild-to-moderate sunken cheeks and lower face laxity |
Assessment | Vectra XT 3D imaging + Merz Scale at 12 weeks |
Findings | Volumetric increases along cheek and jawline; improvement in sunken cheeks and sagging jawline on Merz Scale |
Side effects | Mild erythema and swelling — resolved within hours to days |
⚠️ Retracted study note: Hwang et al. (2024) published in Skin Research and Technology was retracted in November 2025. The 82% satisfaction figure from that paper is not cited here as a result. |
5. Volnewmer vs. HIFU (Ultraformer) — A Mechanism-Based Comparison
'Which is better?' is the wrong question. The right question is: which technology addresses which problem in which tissue layer?
Feature | Volnewmer (Monopolar RF) | HIFU / Ultraformer (Focused Ultrasound) |
Energy type | Electromagnetic wave (RF) | Mechanical sound wave (ultrasound) |
Primary target layer | Dermis + subdermis (bulk heating) | SMAS fascia layer (focal coagulation) |
Mechanism | Collagen denaturation + diffuse thermal stimulation | Focal thermal coagulation points |
Ideal candidate | Sufficient skin thickness; cheeks, neck, periorbital | Significant laxity; jawline, neck, SMAS lifting |
Fat effect | Minimal — primarily collagen-focused | May affect subcutaneous fat (contouring) |
Comfort level | Continuous water cooling → more comfortable | Focal points can produce sharp pain sensation |
Combination use | Complementary with HIFU | Complementary with RF |
Clinical decision factors: degree and location of laxity; fat-to-collagen-to-muscle ratio in the target area; patient comfort threshold; whether combination approach is appropriate. These two technologies are more often complementary than competing. |
6. Who Is a Suitable Candidate? Contraindications
Likely suitable for:
• Mild-to-moderate facial and neck laxity
• Patients with sufficient skin thickness
• Periorbital fine lines and laxity (specialized I-tip)
• Volumetric deficit in the cheek area
• Those seeking non-invasive alternatives to surgery
Contraindications (absolute/relative):
• Metal implants, plates, or wires in the treatment area
• Active infection or skin disease in the area
• Pregnancy
• Pacemaker or internal defibrillator
• Collagen or connective tissue disorders
• Invasive procedure in the same area within 6 months
7. Realistic Timeline: When to Expect What
Timepoint | Biological Process | Patient Experience |
During treatment | Immediate thermal collagen contraction | Warm pressure sensation |
First hours | Reactive oedema and erythema | Mild redness — typically resolves within hours |
Weeks 1–2 | Inflammatory phase — fibroblast activation begins | Possible mild tightness sensation |
Weeks 4–8 | Neocollagenesis — Type I/III collagen synthesis | Progressive improvement in skin firmness |
Months 2–3 | ECM remodeling reaches peak | Most pronounced results typically in this window |
6+ months | Collagen remodeling continues | Duration of effect varies individually |
Individual variation is substantial. Age, skin thickness, sun damage, smoking history, and connective tissue characteristics all influence outcomes. Clinical study values represent group averages. |
8. About the Clinic — Kırklareli, Turkey
Kırklareli is located approximately 220–240 km from Istanbul (approx. 2.5 hours by car on the TEM motorway). It is 60 km from Edirne, 40 km from Lüleburgaz, and approximately 150 km from Sofia, Bulgaria.
Dr. Kağan Cingöz is a dermatology specialist, founding faculty member at Kırklareli University School of Medicine (Dermatology), and an official trainer for Classys Turkey — the manufacturer of Volnewmer and Ultraformer. The trainer designation reflects a standardization and knowledge-transfer role, not merely device operation.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Clinical outcomes vary between individuals. Treatment decisions are made by Dr. Kağan Cingöz following individual consultation. No results are guaranteed or implied. Prepared in accordance with Turkish medical promotion regulations. |
📍 Clinic: İstasyon Mah. Edirne Caddesi No:102, Kırklareli, Turkey | 📱 +90 555 209 09 39 | 🌐 www.drkagancingoz.com



Comments